Endothelins and pulmonary hypertension, what directions for the near future?

Eddahibi S., Adnot S.

Source: Eur Respir J 2001; 18: 1-4
Journal Issue: July

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eddahibi S., Adnot S.. Endothelins and pulmonary hypertension, what directions for the near future?. Eur Respir J 2001; 18: 1-4

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary arterial hypertension: screening challenges in systemic sclerosis and future directions
Source: Eur Respir J, 49 (5) 1700522; 10.1183/13993003.00522-2017
Year: 2017



Chronic post-embolic pulmonary hypertension: a new target for medical therapies?},
Source: Eur Respir Rev 2013; 22: 258-264
Year: 2013



Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better?
Source: Eur Respir J 2006 Oct 01;28(4):683-686
Year: 2006


Pulmonary arterial hypertension: bridging the present to the future
Source: Eur Respir Rev 2012 21: 267-270
Year: 2012


Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?},
Source: Eur Respir Rev 2013; 22: 217-226
Year: 2013



Future perspectives in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 381-389
Year: 2016



Pulmonary arterial hypertension registries: past, present and into the future
Source: Eur Respir Rev, 28 (154) 190128; 10.1183/16000617.0128-2019
Year: 2019



Fibrocytes: potential new therapeutic targets for pulmonary hypertension?
Source: Eur Respir J 2010; 36: 1232-1235
Year: 2010


The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012


The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm
Source: Eur Respir J 2015; 46: 299-302
Year: 2015


Novel therapeutic perspectives in pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: 193-194
Year: 2003


Pulmonary hypertension: future therapies
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=84
Year: 2004

Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
Source: Eur Respir J, 53 (6) 1900583; 10.1183/13993003.00583-2019
Year: 2019



Antithrombotics in pulmonary hypertension: more work needed before we turn to newer agents!
Source: Eur Respir J 2013; 41: 775-777
Year: 2013


The importance of patient perspectives in pulmonary hypertension
Source: Eur Respir J, 53 (1) 1801919; 10.1183/13993003.01919-2018
Year: 2019



Idiopathic pulmonary fibrosis: current challenges and future perspectives
Source: Eur Respir Rev 2013; 22: 103-105
Year: 2013